TreeWAS – Variant ID: rs8002180

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
U89.8 Agent resistant to other single specified antibiotic	0.138	0.862	0.000
U89 Agent resistant to other and unspecified antibiotics	0.134	0.865	0.000
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.133	0.867	0.000
U88 Agent resistant to multiple antibiotics	0.131	0.869	0.000
B07 Viral warts	0.000	0.876	0.124
Chapter XXII Codes for special purposes	0.105	0.895	0.000
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.100	0.900	0.000
U89.9 Agent resistant to unspecified antibiotic	0.097	0.903	0.000
U80 Agent resistant to penicillin and related antibiotics	0.096	0.904	0.000
U84 Resistance to other antimicrobial drugs	0.095	0.904	0.000
U83 Resistance to other antibiotics	0.095	0.904	0.000
U82 Resistance to betalactam antibiotics	0.095	0.904	0.000
U85 Resistance to antineoplastic drugs	0.095	0.904	0.000
U80.0 Penicillin resistant agent	0.095	0.905	0.000
U81 Agent resistant to vancomycin and related antibiotics	0.075	0.925	0.000
U80.8 Agent resistant to other penicillin-related antibiotic	0.074	0.925	0.000
U51 Admission status on psychiatric patients	0.074	0.926	0.000
U50 Level of care administered to neonates	0.072	0.928	0.000
U07 Emergency use of U07	0.072	0.928	0.000
U06 Emergency use of U06	0.072	0.928	0.000
U04 Severe acute respiratory syndrome [SARS]	0.072	0.928	0.000
U52 First in a series of a regular day/night admissions	0.072	0.928	0.000
U82.9 Resistance to betalactam antibiotics, unspecified	0.068	0.931	0.000
U82.8 Resistance to other betalactam antibiotics	0.068	0.931	0.000
U82.2 Extended spectrum betalactamase (ESBL) resistance	0.068	0.931	0.000
U82.1 Resistance to methicillin	0.068	0.931	0.000
U82.0 Resistance to penicillin	0.068	0.931	0.000
U83.9 Resistance to unspecified antibiotic	0.068	0.931	0.000
U83.8 Resistance to other single specified antibiotic	0.068	0.931	0.000
U83.7 Resistance to multiple antibiotics	0.068	0.931	0.000
U83.2 Resistance to quinolones	0.068	0.931	0.000
U83.1 Resistance to other vancomycin related antibiotics	0.068	0.931	0.000
U83.0 Resistance to vancomycin	0.068	0.931	0.000
U84.9 Resistance to unspecified antimicrobial drugs	0.068	0.931	0.000
U84.8 Resistance to other specified antimicrobial drug	0.068	0.931	0.000
U84.7 Resistance to multiple antimicrobial drugs	0.068	0.931	0.000
U84.3 Resistance to tuberculostatic drug(s)	0.068	0.931	0.000
U84.2 Resistance to antiviral drug(s)	0.068	0.931	0.000
U84.1 Resistance to antifungal drug(s)	0.068	0.931	0.000
U84.0 Resistance to antiparasitic drug(s)	0.068	0.931	0.000
U81.0 Vancomycin resistant agent	0.057	0.943	0.000
U51.1 Previously admitted to a psychiatric hospital of the provider	0.056	0.944	0.000
U81.8 Agent resistant to other vancomycin-related antibiotic	0.054	0.946	0.000
U51.2 Previously admitted to a psychiatric hospital of another provider	0.053	0.947	0.000
U51.0 Not Previously admitted to a psyciatric hospital	0.052	0.948	0.000
U04.9 Severe acute respiratory syndrome [SARS], unspecified	0.051	0.948	0.000
U06.9 Emergency use of U06.9	0.051	0.948	0.000
U06.8 Emergency use of U06.8	0.051	0.948	0.000
U06.7 Emergency use of U06.7	0.051	0.948	0.000
U06.6 Emergency use of U06.6	0.051	0.948	0.000
U06.5 Emergency use of U06.5	0.051	0.948	0.000
U06.4 Emergency use of U06.4	0.051	0.948	0.000
U06.3 Emergency use of U06.3	0.051	0.948	0.000
U06.2 Emergency use of U06.2	0.051	0.948	0.000
U06.1 Emergency use of U06.1	0.051	0.948	0.000
U06.0 Emergency use of U06.0	0.051	0.948	0.000
U07.9 Emergency use of U07.9	0.051	0.948	0.000
U07.8 Emergency use of U07.8	0.051	0.948	0.000
U07.7 Emergency use of U07.7	0.051	0.948	0.000
U07.6 Emergency use of U07.6	0.051	0.948	0.000
U07.5 Emergency use of U07.5	0.051	0.948	0.000
U07.4 Emergency use of U07.4	0.051	0.948	0.000
U07.3 Emergency use of U07.3	0.051	0.948	0.000
U07.2 Emergency use of U07.2	0.051	0.948	0.000
U07.1 Emergency use of U07.1	0.051	0.948	0.000
U07.0 Emergency use of U07.0	0.051	0.948	0.000
U50.9 Inquest Adjourned Death	0.051	0.948	0.000
U50.3 Level of care administered to neonates (Maximal Intensive Care)	0.051	0.948	0.000
U50.2 Level of care administered to neonates (High Dependancy Intensive Care)	0.051	0.948	0.000
U50.1 Level of care administered to neonates (Special Care)	0.051	0.948	0.000
U50.0 Level of care administered to neonates (Normal Care)	0.051	0.948	0.000
U80.1 Methicillin resistant agent	0.051	0.949	0.000
K86.1 Other chronic pancreatitis	0.048	0.952	0.000
K86.3 Pseudocyst of pancreas	0.039	0.961	0.000
K86 Other diseases of pancreas	0.038	0.962	0.000
C77.1 Intrathoracic lymph nodes	0.034	0.966	0.000
K86.2 Cyst of pancreas	0.033	0.967	0.000
C77.2 Intra-abdominal lymph nodes	0.033	0.967	0.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.028	0.972	0.000
K86.0 Alcohol-induced chronic pancreatitis	0.026	0.974	0.000
C77.0 Lymph nodes of head, face and neck	0.024	0.976	0.000
C77.8 Lymph nodes of multiple regions	0.021	0.979	0.000
K86.9 Disease of pancreas, unspecified	0.019	0.981	0.000
C77.9 Lymph node, unspecified	0.018	0.982	0.000
C77.3 Axillary and upper limb lymph nodes	0.017	0.983	0.000
N80.0 Endometriosis of uterus	0.000	0.983	0.017
R17 Unspecified jaundice	0.000	0.983	0.017
K86.8 Other specified diseases of pancreas	0.011	0.989	0.000
R80 Isolated proteinuria	0.000	0.989	0.011
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.000	0.989	0.011
C77.4 Inguinal and lower limb lymph nodes	0.009	0.991	0.000
C77.5 Intrapelvic lymph nodes	0.009	0.991	0.000
B06 Rubella [German measles]	0.000	0.992	0.008
B05 Measles	0.000	0.992	0.008
B09 Unspecified viral infection characterised by skin and mucous membrane lesions	0.000	0.992	0.008
B04 Monkeypox	0.000	0.992	0.008
B03 Smallpox	0.000	0.992	0.008
B01 Varicella [chickenpox]	0.000	0.992	0.007
B08 Other viral infections characterised by skin and mucous membrane lesions, not elsewhere classified	0.000	0.994	0.006
Z04.1 Examination and observation following transport accident	0.006	0.994	0.000
B02 Zoster [herpes zoster]	0.000	0.994	0.006
B05.9 Measles without complication	0.000	0.994	0.006
B05.8 Measles with other complications	0.000	0.994	0.006
B05.4 Measles with intestinal complications	0.000	0.994	0.006
B05.3 Measles complicated by otitis media	0.000	0.994	0.006
B05.2 Measles complicated by pneumonia	0.000	0.994	0.006
B05.1 Measles complicated by meningitis	0.000	0.994	0.006
B05.0 Measles complicated by encephalitis	0.000	0.994	0.006
B06.9 Rubella without complication	0.000	0.994	0.006
B06.8 Rubella with other complications	0.000	0.994	0.006
B06.0 Rubella with neurological complications	0.000	0.994	0.006
C71.9 Brain, unspecified	0.000	0.994	0.006
B01.8 Varicella with other complications	0.000	0.994	0.005
B01.2 Varicella pneumonia	0.000	0.994	0.005
B01.1 Varicella encephalitis	0.000	0.994	0.005
B01.0 Varicella meningitis	0.000	0.994	0.005
M79.67 Pain in limb (Ankle and foot)	0.000	0.994	0.006
L40.0 Psoriasis vulgaris	0.006	0.994	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.006	0.994	0.000
C71.2 Temporal lobe	0.000	0.995	0.005
C71 Malignant neoplasm of brain	0.000	0.995	0.005
B01.9 Varicella without complications	0.000	0.995	0.005
B02.3 Zoster ocular disease	0.000	0.995	0.005
Z35.5 Supervision of elderly primigravida	0.005	0.995	0.000
T51.0 Ethanol	0.000	0.995	0.005
B02.8 Zoster with other complications	0.000	0.995	0.005
B08.8 Other specified viral infections characterised by skin and mucous membrane lesions	0.000	0.995	0.005
B08.5 Enteroviral vesicular pharyngitis	0.000	0.995	0.005
B08.4 Enteroviral vesicular stomatitis with exanthem	0.000	0.995	0.005
B08.3 Erythema infectiosum [fifth disease]	0.000	0.995	0.005
B08.2 Exanthema subitum [sixth disease]	0.000	0.995	0.005
B08.0 Other orthopoxvirus infections	0.000	0.995	0.005
Z35.8 Supervision of other high-risk pregnancies	0.005	0.995	0.000
B02.7 Disseminated zoster	0.000	0.995	0.005
B02.1 Zoster meningitis	0.000	0.995	0.005
B02.0 Zoster encephalitis	0.000	0.995	0.005
C71.4 Occipital lobe	0.000	0.995	0.004
B02.2 Zoster with other nervous system involvement	0.000	0.996	0.004
Q18.0 Sinus, fistula and cyst of branchial cleft	0.004	0.996	0.000
M54.46 Lumbago with sciatica (Lumbar region)	0.000	0.996	0.004
C71.1 Frontal lobe	0.000	0.996	0.004
Z35 Supervision of high-risk pregnancy	0.004	0.996	0.000
R80-R82 Abnormal findings on examination of urine, without diagnosis	0.000	0.996	0.004
C71.7 Brain stem	0.000	0.996	0.004
C71.6 Cerebellum	0.000	0.996	0.004
C71.5 Cerebral ventricle	0.000	0.996	0.004
C71.0 Cerebrum, except lobes and ventricles	0.000	0.996	0.004
D39.1 Ovary	0.004	0.996	0.000
Z35.0 Supervision of pregnancy with history of infertility	0.004	0.996	0.000
C61 Malignant neoplasm of prostate	0.000	0.996	0.004
E61.1 Iron deficiency	0.004	0.996	0.000
R82.9 Other and unspecified abnormal finding in urine	0.000	0.996	0.004
Z35.9 Supervision of high-risk pregnancy, unspecified	0.004	0.996	0.000
M54.49 Lumbago with sciatica (Site unspecified)	0.000	0.996	0.004
C71.8 Overlapping lesion of brain	0.000	0.996	0.003
Z35.1 Supervision of pregnancy with history of abortive outcome	0.003	0.996	0.000
R82 Other abnormal findings in urine	0.000	0.996	0.003
Q18 Other congenital malformations of face and neck	0.003	0.996	0.000
T51 Toxic effect of alcohol	0.000	0.997	0.003
T51.9 Alcohol, unspecified	0.000	0.997	0.003
C69 Malignant neoplasm of eye and adnexa	0.000	0.997	0.003
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.000	0.997	0.003
Q12.0 Congenital cataract	0.003	0.997	0.000
B08.1 Molluscum contagiosum	0.001	0.997	0.003
M54.4 Lumbago with sciatica	0.000	0.997	0.003
Z35.7 Supervision of high-risk pregnancy due to social problems	0.003	0.997	0.000
Z35.6 Supervision of very young primigravida	0.003	0.997	0.000
Z35.3 Supervision of pregnancy with history of insufficient antenatal care	0.003	0.997	0.000
C69.3 Choroid	0.000	0.997	0.003
B00 Herpesviral [herpes simplex] infections	0.001	0.997	0.003
C71.3 Parietal lobe	0.000	0.997	0.003
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.003	0.997	0.000
Q89.2 Congenital malformations of other endocrine glands	0.003	0.997	0.000
R82.4 Acetonuria	0.000	0.997	0.003
C82.0 Small cleaved cell, follicular	0.003	0.997	0.000
T43.2 Other and unspecified antidepressants	0.000	0.997	0.003
C69.0 Conjunctiva	0.000	0.997	0.003
Q12 Congenital lens malformations	0.003	0.997	0.000
R41.2 Retrograde amnesia	0.000	0.997	0.003
T78.3 Angioneurotic oedema	0.003	0.997	0.000
I11.9 Hypertensive heart disease without (congestive) heart failure	0.003	0.997	0.000
C82.2 Large cell, follicular	0.003	0.997	0.000
N80.1 Endometriosis of ovary	0.000	0.997	0.003
Q18.1 Preauricular sinus and cyst	0.003	0.997	0.000
R82.6 Abnormal urine levels of substances chiefly nonmedicinal as to source	0.000	0.997	0.003
R82.3 Haemoglobinuria	0.000	0.997	0.003
R82.2 Biliuria	0.000	0.997	0.003
R82.0 Chyluria	0.000	0.997	0.003
Q18.9 Congenital malformation of face and neck, unspecified	0.003	0.997	0.000
Q18.8 Other specified congenital malformations of face and neck	0.003	0.997	0.000
Q18.7 Microcheilia	0.003	0.997	0.000
Q18.6 Macrocheilia	0.003	0.997	0.000
Q18.5 Microstomia	0.003	0.997	0.000
Q18.4 Macrostomia	0.003	0.997	0.000
Q18.3 Webbing of neck	0.003	0.997	0.000
Q18.2 Other branchial cleft malformations	0.003	0.997	0.000
Q10-Q18 Congenital malformations of eye, ear, face and neck	0.003	0.997	0.000
R82.1 Myoglobinuria	0.000	0.997	0.003
T51.8 Other alcohols	0.000	0.997	0.003
T51.3 Fusel oil	0.000	0.997	0.003
T51.2 2-Propanol	0.000	0.997	0.003
T51.1 Methanol	0.000	0.997	0.003
G35 Multiple sclerosis	0.003	0.997	0.000
T39.0 Salicylates	0.000	0.997	0.003
T68 Hypothermia	0.003	0.997	0.000
C69.8 Overlapping lesion of eye and adnexa	0.000	0.997	0.003
C69.6 Orbit	0.000	0.997	0.003
C69.5 Lachrymal gland and duct	0.000	0.997	0.003
C69.4 Ciliary body	0.000	0.997	0.003
C69.2 Retina	0.000	0.997	0.003
C69.1 Cornea	0.000	0.997	0.003
I15.1 Hypertension secondary to other renal disorders	0.003	0.997	0.000
M54.47 Lumbago with sciatica (Lumbosacral region)	0.000	0.997	0.003
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.000	0.997	0.003
C82.4 Follicular lymphoma grade IIIb	0.003	0.997	0.000
M54.48 Lumbago with sciatica (Sacral and sacrococcygeal region)	0.000	0.997	0.003
M54.45 Lumbago with sciatica (Thoracolumbar region)	0.000	0.997	0.003
M54.44 Lumbago with sciatica-Thoracic	0.000	0.997	0.003
M54.43 Lumbago with sciatica-Cervicothoracic	0.000	0.997	0.003
M54.42 Lumbago with sciatica-Cervical	0.000	0.997	0.003
M54.41 Lumbago with sciatica-Occipit-atl-axl	0.000	0.997	0.003
M54.40 Lumbago with sciatica (Multiple sites in spine)	0.000	0.997	0.003
R82.5 Elevated urine levels of drugs, medicaments and biological substances	0.000	0.997	0.002
B00.7 Disseminated herpesviral disease	0.001	0.997	0.002
B00.3 Herpesviral meningitis	0.001	0.997	0.002
B00.0 Eczema herpeticum	0.001	0.997	0.002
C69.9 Eye, unspecified	0.000	0.997	0.002
R30.0 Dysuria	0.003	0.997	0.000
C70 Malignant neoplasm of meninges	0.000	0.997	0.002
C82.6 Cutaneous follicle centre lymphoma	0.002	0.997	0.000
C82.5 Diffuse follicle centre lymphoma	0.002	0.997	0.000
B00.8 Other forms of herpesviral infection	0.001	0.997	0.002
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.002	0.997	0.000
G11.9 Hereditary ataxia, unspecified	0.002	0.997	0.000
R82.7 Abnormal findings on microbiological examination of urine	0.000	0.997	0.002
R81 Glycosuria	0.000	0.998	0.002
Z35.4 Supervision of pregnancy with grand multiparity	0.002	0.998	0.000
T78.4 Allergy, unspecified	0.002	0.998	0.000
Q12.9 Congenital lens malformation, unspecified	0.002	0.998	0.000
Q12.8 Other congenital lens malformations	0.002	0.998	0.000
Q12.4 Spherophakia	0.002	0.998	0.000
Q12.3 Congenital aphakia	0.002	0.998	0.000
Q12.2 Coloboma of lens	0.002	0.998	0.000
Q12.1 Congenital displaced lens	0.002	0.998	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
C82.3 Follicular lymphoma grade IIIa	0.002	0.998	0.000
S06.20 Diffuse brain injury (without open intracranial wound)	0.000	0.998	0.002
D37.4 Colon	0.002	0.998	0.000
B00.1 Herpesviral vesicular dermatitis	0.000	0.998	0.002
C82.1 Mixed small cleaved and large cell, follicular	0.002	0.998	0.000
B00.4 Herpesviral encephalitis	0.001	0.998	0.002
Q14 Congenital malformations of posterior segment of eye	0.002	0.998	0.000
T78 Adverse effects, not elsewhere classified	0.002	0.998	0.000
Q17 Other congenital malformations of ear	0.002	0.998	0.000
B00.2 Herpesviral gingivostomatitis and pharyngotonsillitis	0.001	0.998	0.002
Q16 Congenital malformations of ear causing impairment of hearing	0.002	0.998	0.000
Q13 Congenital malformations of anterior segment of eye	0.002	0.998	0.000
Q11 Anophthalmos, microphthalmos and macrophthalmos	0.002	0.998	0.000
M79.84 Other specified soft tissue disorders (Hand)	0.002	0.998	0.000
B02.9 Zoster without complication	0.000	0.998	0.002
C72.9 Central nervous system, unspecified	0.000	0.998	0.002
C72.8 Overlapping lesion of brain and other parts of central nervous system	0.000	0.998	0.002
C72.5 Other and unspecified cranial nerves	0.000	0.998	0.002
C72.4 Acoustic nerve	0.000	0.998	0.002
C72.3 Optic nerve	0.000	0.998	0.002
C72.2 Olfactory nerve	0.000	0.998	0.002
C72.1 Cauda equina	0.000	0.998	0.002
C72.0 Spinal cord	0.000	0.998	0.002
Q15 Other congenital malformations of eye	0.002	0.998	0.000
Q10 Congenital malformations of eyelid, lachrymal apparatus and orbit	0.002	0.998	0.000
D05.9 Carcinoma in situ of breast, unspecified	0.002	0.998	0.000
B00.5 Herpesviral ocular disease	0.001	0.998	0.001
C70.9 Meninges, unspecified	0.000	0.998	0.002
C70.1 Spinal meninges	0.000	0.998	0.002
K25.3 Acute without haemorrhage or perforation	0.000	0.998	0.002
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
D37.1 Stomach	0.002	0.998	0.000
Z63.5 Disruption of family by separation and divorce	0.000	0.998	0.002
L27.0 Generalised skin eruption due to drugs and medicaments	0.002	0.998	0.000
D39.9 Female genital organ, unspecified	0.002	0.998	0.000
D39.7 Other female genital organs	0.002	0.998	0.000
D39.2 Placenta	0.002	0.998	0.000
D46.7 Other myelodysplastic syndromes	0.002	0.998	0.000
T78.0 Anaphylactic shock due to adverse food reaction	0.002	0.998	0.000
I15.9 Seconday hypertension, unspecified	0.002	0.998	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.998	0.002
Q14.1 Congenital malformation of retina	0.002	0.998	0.000
C70.0 Cerebral meninges	0.000	0.998	0.002
D39.0 Uterus	0.002	0.998	0.000
Q17.5 Prominent ear	0.002	0.998	0.000
D46 Myelodysplastic syndromes	0.002	0.998	0.000
Q89 Other congenital malformations, not elsewhere classified	0.002	0.998	0.000
B00.9 Herpesviral infection, unspecified	0.001	0.998	0.001
D46.9 Myelodysplastic syndrome, unspecified	0.002	0.998	0.000
D37.0 Lip, oral cavity and pharynx	0.002	0.998	0.000
Q14.9 Congenital malformation of posterior segment of eye, unspecified	0.002	0.998	0.000
Q14.8 Other congenital malformations of posterior segment of eye	0.002	0.998	0.000
Q14.3 Congenital malformation of choroid	0.002	0.998	0.000
Q14.2 Congenital malformation of optic disk	0.002	0.998	0.000
Q14.0 Congenital malformation of vitreous humour	0.002	0.998	0.000
Q17.9 Congenital malformation of ear, unspecified	0.002	0.998	0.000
Q17.8 Other specified congenital malformations of ear	0.002	0.998	0.000
Q17.4 Misplaced ear	0.002	0.998	0.000
Q17.3 Other misshapen ear	0.002	0.998	0.000
Q17.2 Microtia	0.002	0.998	0.000
Q17.1 Macrotia	0.002	0.998	0.000
Q17.0 Accessory auricle	0.002	0.998	0.000
Q51.3 Bicornate uterus	0.000	0.998	0.002
T45.2 Vitamins, not elsewhere classified	0.000	0.998	0.002
T78.9 Adverse effect, unspecified	0.002	0.998	0.000
Q76.4 Other congenital malformations of spine, not associated with scoliosis	0.002	0.998	0.000
I15 Secondary hypertension	0.002	0.998	0.000
T66-T78 Other and unspecified effects of external causes	0.002	0.998	0.000
C02.3 Anterior two-thirds of tongue, part unspecified	0.002	0.998	0.000
Q11.3 Macrophthalmos	0.002	0.998	0.000
Q11.2 Microphthalmos	0.002	0.998	0.000
Q11.1 Other anophthalmos	0.002	0.998	0.000
Q11.0 Cystic eyeball	0.002	0.998	0.000
Q13.9 Congenital malformation of anterior segment of eye, unspecified	0.002	0.998	0.000
Q13.8 Other congenital malformations of anterior segment of eye	0.002	0.998	0.000
Q13.5 Blue sclera	0.002	0.998	0.000
Q13.4 Other congenital corneal malformations	0.002	0.998	0.000
Q13.3 Congenital corneal opacity	0.002	0.998	0.000
Q13.2 Other congenital malformations of iris	0.002	0.998	0.000
Q13.1 Absence of iris	0.002	0.998	0.000
Q13.0 Coloboma of iris	0.002	0.998	0.000
Q16.9 Congenital malformation of ear causing impairment of hearing, unspecified	0.002	0.998	0.000
Q16.5 Congenital malformation of inner ear	0.002	0.998	0.000
Q16.4 Other congenital malformations of middle ear	0.002	0.998	0.000
Q16.3 Congenital malformation of ear ossicles	0.002	0.998	0.000
Q16.2 Absence of eustachian tube	0.002	0.998	0.000
Q16.1 Congenital absence, atresia and stricture of auditory canal (external)	0.002	0.998	0.000
Q16.0 Congenital absence of (ear) auricle	0.002	0.998	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.998	0.002
Q51.8 Other congenital malformations of uterus and cervix	0.000	0.998	0.002
C02.9 Tongue, unspecified	0.002	0.998	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.002	0.998	0.000
D46.2 Refractory anaemia with excess of blasts	0.002	0.998	0.000
Q66.0 Talipes equinovarus	0.002	0.998	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.998	0.002
C02.1 Border of tongue	0.002	0.998	0.000
Q15.9 Congenital malformation of eye, unspecified	0.002	0.998	0.000
Q15.8 Other specified congenital malformations of eye	0.002	0.998	0.000
Q66.7 Pes cavus	0.002	0.998	0.000
Q66 Congenital deformities of feet	0.002	0.998	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
Q10.7 Congenital malformation of orbit	0.002	0.998	0.000
Q10.6 Other congenital malformations of lachrymal apparatus	0.002	0.998	0.000
Q10.5 Congenital stenosis and stricture of lachrymal duct	0.002	0.998	0.000
Q10.4 Absence and agenesis of lachrymal apparatus	0.002	0.998	0.000
Q10.3 Other congenital malformations of eyelid	0.002	0.998	0.000
Q10.2 Congenital entropion	0.002	0.998	0.000
Q10.1 Congenital ectropion	0.002	0.998	0.000
T43.6 Psychostimulants with abuse potential	0.000	0.998	0.002
C02 Malignant neoplasm of other and unspecified parts of tongue	0.002	0.998	0.000
E61 Deficiency of other nutrient elements	0.002	0.998	0.000
S06.90 Intracranial injury, unspecified (without open intracranial wound)	0.000	0.998	0.002
I82.8 Embolism and thrombosis of other specified veins	0.000	0.998	0.002
Q51.2 Other doubling of uterus	0.000	0.998	0.002
R59.1 Generalised enlarged lymph nodes	0.002	0.998	0.000
T43.9 Psychotropic drug, unspecified	0.000	0.998	0.002
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.998	0.002
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.998	0.002
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.998	0.002
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.998	0.002
W27.6 Industrial and construction area	0.002	0.998	0.000
T71 Asphyxiation	0.002	0.998	0.000
D46.1 Refractory anaemia with sideroblasts	0.002	0.998	0.000
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.002	0.998	0.000
Q51 Congenital malformations of uterus and cervix	0.000	0.998	0.002
S06.2 Diffuse brain injury	0.000	0.998	0.002
T78.8 Other adverse effects, not elsewhere classified	0.002	0.998	0.000
Q15.0 Congenital glaucoma	0.001	0.998	0.000
R82.8 Abnormal findings on cytological and histological examination of urine	0.000	0.998	0.001
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)	0.000	0.998	0.002
D46.5 Refractory anaemia with multi-lineage dysplasia	0.002	0.998	0.000
D48.7 Other specified sites	0.002	0.998	0.000
D68.2 Hereditary deficiency of other clotting factors	0.000	0.998	0.002
Q66.6 Other congenital valgus deformities of feet	0.002	0.998	0.000
T45.5 Anticoagulants	0.000	0.998	0.002
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.998	0.002
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.998	0.002
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality	0.002	0.998	0.000
D46.3 Refractory anaemia with excess of blasts with transformation	0.002	0.998	0.000
D46.0 Refractory anaemia without sideroblasts, so stated	0.002	0.998	0.000
Q10.0 Congenital ptosis	0.001	0.998	0.000
Q89.9 Congenital malformation, unspecified	0.002	0.998	0.000
Q89.8 Other specified congenital malformations	0.002	0.998	0.000
Q89.7 Multiple congenital malformations, not elsewhere classified	0.002	0.998	0.000
Q89.4 Conjoined twins	0.002	0.998	0.000
Q89.3 Situs inversus	0.002	0.998	0.000
Q89.1 Congenital malformations of adrenal gland	0.002	0.998	0.000
Q89.0 Congenital malformations of spleen	0.002	0.998	0.000
N61 Inflammatory disorders of breast	0.002	0.998	0.000
N80 Endometriosis	0.000	0.998	0.002
I15.8 Other secondary hypertension	0.002	0.998	0.000
I15.2 Hypertension secondary to endocrine disorders	0.002	0.998	0.000
I15.0 Renovascular hypertension	0.002	0.998	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.998	0.002
T74 Maltreatment syndromes	0.002	0.998	0.000
T73 Effects of other deprivation	0.002	0.998	0.000
T69 Other effects of reduced temperature	0.002	0.998	0.000
T67 Effects of heat and light	0.002	0.998	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.998	0.002
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.998	0.002
T39.4 Antirheumatics, not elsewhere classified	0.000	0.998	0.002
T39.2 Pyrazolone derivatives	0.000	0.998	0.002
Q66.3 Other congenital varus deformities of feet	0.002	0.998	0.000
S46.2 Injury of muscle and tendon of other parts of biceps	0.002	0.998	0.000
T31.0 Burns involving less than 10% of body surface	0.000	0.998	0.002
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.998	0.001
T45.8 Other primarily systemic and haematological agents	0.000	0.998	0.001
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.998	0.001
T45.6 Fibrinolysis-affecting drugs	0.000	0.998	0.001
T45.4 Iron and its compounds	0.000	0.998	0.001
T45.3 Enzymes, not elsewhere classified	0.000	0.998	0.001
T70 Effects of air pressure and water pressure	0.001	0.998	0.000
Q66.9 Congenital deformity of feet, unspecified	0.001	0.998	0.000
Q66.5 Congenital pes planus	0.001	0.998	0.000
Q66.4 Talipes calcaneovalgus	0.001	0.998	0.000
Q66.1 Talipes calcaneovarus	0.001	0.998	0.000
T50.8 Diagnostic agents	0.000	0.998	0.001
T50.7 Analeptics and opioid receptor antagonists	0.000	0.998	0.001
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.998	0.001
T50.5 Appetite depressants	0.000	0.998	0.001
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.998	0.001
T50.1 Loop [high-ceiling] diuretics	0.000	0.998	0.001
T50.0 Mineralocorticoids and their antagonists	0.000	0.998	0.001
I11 Hypertensive heart disease	0.002	0.998	0.000
C02.8 Overlapping lesion of tongue	0.001	0.998	0.000
C02.2 Ventral surface of tongue	0.001	0.998	0.000
C02.0 Dorsal surface of tongue	0.001	0.998	0.000
E61.9 Deficiency of nutrient element, unspecified	0.001	0.998	0.000
E61.8 Deficiency of other specified nutrient elements	0.001	0.998	0.000
E61.7 Deficiency of multiple nutrient elements	0.001	0.998	0.000
E61.6 Vanadium deficiency	0.001	0.998	0.000
E61.5 Molybdenum deficiency	0.001	0.998	0.000
E61.4 Chromium deficiency	0.001	0.998	0.000
E61.3 Manganese deficiency	0.001	0.998	0.000
E61.0 Copper deficiency	0.001	0.998	0.000
L27.2 Dermatitis due to ingested food	0.002	0.998	0.000
O66.5 Failed application of vacuum extractor and forceps, unspecified	0.000	0.998	0.002
T78.2 Anaphylactic shock, unspecified	0.002	0.998	0.000
D37.5 Rectum	0.002	0.998	0.000
Q66.2 Metatarsus varus	0.001	0.998	0.000
Z01.7 Laboratory examination	0.002	0.998	0.000
T66 Unspecified effects of radiation	0.001	0.998	0.000
S06.21 Diffuse brain injury (with open intracranial wound)	0.000	0.998	0.001
D46.4 Refractory anaemia, unspecified	0.001	0.998	0.000
Q51.9 Congenital malformation of uterus and cervix, unspecified	0.000	0.998	0.001
Q51.7 Congenital fistulae between uterus and digestive and urinary tracts	0.000	0.998	0.001
Q51.6 Embryonic cyst of cervix	0.000	0.998	0.001
Q51.5 Agenesis and aplasia of cervix	0.000	0.998	0.001
Q51.4 Unicornate uterus	0.000	0.998	0.001
Q51.0 Agenesis and aplasia of uterus	0.000	0.998	0.001
V80.9 Rider or occupant injured in other and unspecified transport accidents	0.002	0.998	0.000
Z63.4 Disappearance and death of family member	0.000	0.998	0.002
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.998	0.001
D48.2 Peripheral nerves and autonomic nervous system	0.001	0.998	0.000
L40.1 Generalised pustular psoriasis	0.002	0.998	0.000
O42.0 Premature rupture of membranes, onset of labour within 24 hours	0.002	0.998	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.998	0.001
Q76 Congenital malformations of spine and bony thorax	0.001	0.998	0.000
M16.1 Other primary coxarthrosis	0.000	0.998	0.002
O99.2 Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium	0.002	0.998	0.000
S46.3 Injury of muscle and tendon of triceps	0.001	0.998	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.998	0.001
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.998	0.001
T46.7 Peripheral vasodilators	0.000	0.998	0.001
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.998	0.001
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.998	0.001
C02.4 Lingual tonsil	0.001	0.998	0.000
S06.9 Intracranial injury, unspecified	0.000	0.998	0.001
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.998	0.001
Z63.8 Other specified problems related to primary support group	0.000	0.998	0.001
G11 Hereditary ataxia	0.001	0.998	0.000
T75 Effects of other external causes	0.001	0.998	0.000
N80.6 Endometriosis in cutaneous scar	0.000	0.998	0.001
O35.9 Maternal care for (suspected) foetal abnormality and damage, unspecified	0.000	0.998	0.001
V44.5 Driver injured in traffic accident	0.001	0.998	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.998	0.001
M24.28 Disorder of ligament (Other)	0.001	0.999	0.000
S06.6 Traumatic subarachnoid haemorrhage	0.000	0.999	0.001
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.999	0.001
T67.9 Effects of heat and light, unspecified	0.001	0.999	0.000
T67.8 Other effects of heat and light	0.001	0.999	0.000
T67.7 Heat oedema	0.001	0.999	0.000
T67.6 Heat fatigue, transient	0.001	0.999	0.000
T67.5 Heat exhaustion, unspecified	0.001	0.999	0.000
T67.4 Heat exhaustion due to salt depletion	0.001	0.999	0.000
T67.3 Heat exhaustion, anhydrotic	0.001	0.999	0.000
T67.2 Heat cramp	0.001	0.999	0.000
T67.1 Heat syncope	0.001	0.999	0.000
T67.0 Heatstroke and sunstroke	0.001	0.999	0.000
T69.9 Effect of reduced temperature, unspecified	0.001	0.999	0.000
T69.8 Other specified effects of reduced temperature	0.001	0.999	0.000
T69.1 Chilblains	0.001	0.999	0.000
T69.0 Immersion hand and foot	0.001	0.999	0.000
T73.9 Effect of deprivation, unspecified	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations